Skip to main content
OpenTrials
Completed

NCT Number: NCT06339229

Postoperative New-onset Proteinuria and Adverse Outcomes.

We aimed to assess the association between postoperative new-onset proteinuria, all-cause mortality, and decline in kidney function in Chinese people who underwent surgery. The exposure variable was the dipstick proteinuria values from the initial postoperative urinalysis within 30 days after surgery, categorized as negative, trace, 1+, and ≥2+. The primary outcome was 30-day mortality. The secondary outcomes included 1-year mortality and composite kidney outcome assessed using the postoperative estimated glomerular filtration rate.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • surgery patients

Exclusion criteria

  • kidney or urinary surgery
  • missing urinalysis results
  • dipstick proteinuria indicated a value of "≥ trace" at least once preoperatively
  • with dialysis, end-stage renal disease, or with urinary tract infection at baseline
  • missing follow-up information

Treatment and study plan

proteinuria

Other

dipstick proteinuria values negative, trace, 1+, and ≥2+

Primary outcomes

  1. mortality

    Time frame: 30-day

Sponsors and collaborators

Lead sponsor

Yaozhong Kong

Other

Registry information

Official study title

Association Between Postoperative New-onset Proteinuria and Adverse Outcomes: a Retrospective Cohort Study.

Important dates

Study start
2000
Primary completion
2022
Study completion
2023
First posted
Apr 1, 2024
Registry last updated
Apr 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.